Neurocrine Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NBIX Nasdaq 2836 http://www.neurocrine.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neurocrine Biosciences, Inc.

5 Stocks That Are Screaming Buys Right Now - Jun 20th, 2018 5:52 am
Versartis Stock and Its Consistent Rise in the Week Ended June 8 - Jun 12th, 2018 6:26 am
Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego - Jun 8th, 2018 2:56 pm
See what the IHS Markit Score report has to say about Neurocrine Biosciences Inc. - Jun 8th, 2018 6:06 am
What You Must Know About Neurocrine Biosciences Inc’s (NASDAQ:NBIX) Financial Strength - Jun 2nd, 2018 2:34 pm
Free Technical Insights on OPKO Health and Three Other Biotech Stocks - May 22nd, 2018 5:00 am
Factors of Influence in 2018, Key Indicators and Opportunity within Fred's, Nexstar Broadcasting Group, CNO Financial Group, Neurocrine Biosciences, Kosmos Energy, and Loews — New Research Emphasizes Economic Growth - May 14th, 2018 6:25 am
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference - May 9th, 2018 2:01 pm
3 Top Biotech Stocks to Buy in May - May 9th, 2018 4:00 am
Neurocrine Biosciences Presents New Quality of Life Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia in Patients Treated with Antipsychotics - May 8th, 2018 12:00 pm
NBIX: Strong INGREZZA® Sales Continue in 1Q18; Expanding Sales Team for Future Growth - May 3rd, 2018 8:15 am
Neurocrine Biosciences to Present New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2018 American Psychiatric Association Annual Meeting - May 2nd, 2018 2:14 pm
Edited Transcript of NBIX earnings conference call or presentation 30-Apr-18 9:00pm GMT - May 2nd, 2018 11:52 am
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - May 1st, 2018 5:51 am
Neurocrine: 1Q Earnings Snapshot - Apr 30th, 2018 2:21 pm
Neurocrine Biosciences Reports First Quarter 2018 Financial Results - Apr 30th, 2018 2:01 pm
Neurocrine Biosciences, Inc. to Host Earnings Call - Apr 30th, 2018 11:45 am
AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting - Apr 27th, 2018 6:00 am
What Analysts Recommend for Neurocrine Biosciences in April 2018 - Apr 26th, 2018 3:40 pm
How Neurocrine Biosciences Is Positioned ahead of 1Q18 Earnings - Apr 26th, 2018 2:05 pm